Thioridazine interferences with imipramine metabolism and measurement

Therapeutic Drug Monitoring

Volumn 18, Issue 6, 1996, Pages 729-731

  Maynard, Gary L ^a,b   Soni, Poonam ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b School of Medicine ^*  (United States)

Author keywords

High performance liquid chromatography; Imipramine; Phenothiazine interference; Therapeutic drug monitoring; Thioridazine; Tricyclic antidepressants

Indexed keywords

CYTOCHROME P450 ISOENZYME; DESIPRAMINE; IMIPRAMINE; MESORIDAZINE; SULFORIDAZINE; THIORIDAZINE; VALPROIC ACID;

ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DEPRESSION; DRUG BLOOD LEVEL; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CYTOCHROME P-450 CYP2D6; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; HUMANS; IMIPRAMINE; MALE; THIORIDAZINE;

EID: 0029826987     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199612000-00018     Document Type: Article

References (10)

1. Gelenberg AJ. The P450 family. Biol Ther Psychiatry Newslett 1995;18:29-31.
2. LLerena A, Herraiz AG, Cobaleda J, Johansson I, Dahl ML. Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents. Clin Pharmacol Ther 1993;54: 606-11.
3. DeVane CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 55:12(suppl): 38-45.
4. Spina E, Martines C, Caputi AP, et al. Debrisoquine oxidation phenotype during neuroleptic monotherapy. Eur J Clin Pharmacol 1991;41:467-70.
5. Syvalahti EKG, Lindberg R, Kallio J, DeVocht M. Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br J Clin Pharmacol 1986;22:89-92.
6. Tietz NW, Pruden EL, McPherson RA, Fuhrman SA, eds. Clinical guide to laboratory tests. Philadelphia: W.B. Saunders, 1995:803.
7. Beck W, van Hoek R, Engelhardt H. Application of a diodearray detector in capillary electrophoresis. Electrophoresis 1993;14:540-6.
8. Pappas AA, Taylor EH, Ackerman B. Toxicology and drugs of abuse. In: Howanitz JH, Howanitz PJ, eds. Laboratory medicine: test selection and interpretation. New York: Churchill Livingstone, 1991:395-7.
9. Abbott Diagnostics Division. Tricyclic antidepressants. TDxFLx assays manual. Abbott Park, Illinois: Abbott Laboratories, 1993;45125-111,4-6.
10. Adamczyk M, Rishpaugh JR, Harrington CA, Hartter DE, Hruska RE, Vanderbilt AS. Immunoassay reagents for psychoactive drugs. Part 3. Removal of phenothiazine interferences in the quantification of tricyclic antidepressants. Ther Drug Monit 1993;15:436-9.